U.S. federal trademark · Serial No. 90608789
Metabolism assay used to stratify patients in trials; small molecules intended to target multiple nodes in NAD synthesis pathways identify and characterize altered states of NAD metabolism; drugs and therapies that target NAD metabolism defects in cancer
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.